메뉴 건너뛰기




Volumn 69, Issue 5, 2006, Pages 512-518

Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias

Author keywords

Dyskinesia; Involuntary movement; Levodopa; Motor performance; Parkinson; Tremor

Indexed keywords

LEVODOPA;

EID: 33646077903     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.02.015     Document Type: Article
Times cited : (30)

References (41)
  • 1
    • 0021904659 scopus 로고
    • Pathophysiology of l-dopa-induced abnormal involuntary movements
    • Agid Y., Bonnet A.M., Ruberg M., and Javoy-Agid F. Pathophysiology of l-dopa-induced abnormal involuntary movements. Psychopharmacology 2 Suppl. (1985) 145-159
    • (1985) Psychopharmacology , vol.2 , Issue.SUPPL , pp. 145-159
    • Agid, Y.1    Bonnet, A.M.2    Ruberg, M.3    Javoy-Agid, F.4
  • 2
    • 24344478783 scopus 로고    scopus 로고
    • Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias
    • Agostino R., Bagnato S., Dinapoli L., Modugno N., and Berardelli A. Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias. Clin. Neurophysiol. 116 (2005) 2077-2082
    • (2005) Clin. Neurophysiol. , vol.116 , pp. 2077-2082
    • Agostino, R.1    Bagnato, S.2    Dinapoli, L.3    Modugno, N.4    Berardelli, A.5
  • 4
    • 0030446503 scopus 로고    scopus 로고
    • Handedness and performance variability as factors influencing mirror movement occurrence
    • Armatas C.A., Summers J.J., and Bradshaw J.L. Handedness and performance variability as factors influencing mirror movement occurrence. J. Clin. Exp. Neuropsychol. 18 (1996) 823-835
    • (1996) J. Clin. Exp. Neuropsychol. , vol.18 , pp. 823-835
    • Armatas, C.A.1    Summers, J.J.2    Bradshaw, J.L.3
  • 5
    • 0022492455 scopus 로고
    • Chronic treatment with levodopa, but not bromocriptine induces dyskinesia in MPTP-treated parkinsonian monkeys: correlation with [3H]spiperone binding
    • Bedard P.J., Di Paolo T., Falardeau P., and Boucher R. Chronic treatment with levodopa, but not bromocriptine induces dyskinesia in MPTP-treated parkinsonian monkeys: correlation with [3H]spiperone binding. Brain Res. 379 (1986) 294-299
    • (1986) Brain Res. , vol.379 , pp. 294-299
    • Bedard, P.J.1    Di Paolo, T.2    Falardeau, P.3    Boucher, R.4
  • 6
    • 0035170381 scopus 로고    scopus 로고
    • Pathophysiology of bradykinesia in Parkinson's disease
    • Berardelli A., Rothwell J.C., Thompson P.D., and Hallet M. Pathophysiology of bradykinesia in Parkinson's disease. Brain 124 (2001) 2131-2146
    • (2001) Brain , vol.124 , pp. 2131-2146
    • Berardelli, A.1    Rothwell, J.C.2    Thompson, P.D.3    Hallet, M.4
  • 7
    • 0032924521 scopus 로고    scopus 로고
    • Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits
    • Beuter A., de Geoffroy A., and Edwards R. Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits. Environ. Res. 80 (1999) 64-79
    • (1999) Environ. Res. , vol.80 , pp. 64-79
    • Beuter, A.1    de Geoffroy, A.2    Edwards, R.3
  • 8
    • 0028835737 scopus 로고
    • Continuous administration decreases and pulsatile administration increases behavioural sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys
    • Blanchet P.J., Calon F., Martel J.C., et al. Continuous administration decreases and pulsatile administration increases behavioural sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys. J. Pharmacol. Exp. 272 (1995) 854-859
    • (1995) J. Pharmacol. Exp. , vol.272 , pp. 854-859
    • Blanchet, P.J.1    Calon, F.2    Martel, J.C.3
  • 10
    • 0027135224 scopus 로고
    • A quantitative study of levodopa-induced dyskinesia in Parkinson's disease
    • Caligiuri M.P., and Peterson S. A quantitative study of levodopa-induced dyskinesia in Parkinson's disease. J. Neural. Trans. 6 (1993) 89-98
    • (1993) J. Neural. Trans. , vol.6 , pp. 89-98
    • Caligiuri, M.P.1    Peterson, S.2
  • 11
    • 14944364987 scopus 로고    scopus 로고
    • Impact of the motor complications of Parkinson's disease on the quality of life
    • Chapuis S., Ouchchane L., Metz O., Gerbaud L., and Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov. Disord. 20 (2005) 224-230
    • (2005) Mov. Disord. , vol.20 , pp. 224-230
    • Chapuis, S.1    Ouchchane, L.2    Metz, O.3    Gerbaud, L.4    Durif, F.5
  • 13
    • 0033844750 scopus 로고    scopus 로고
    • Evaluation of a measurement strategy for Parkinson's disease: patient health-related quality of life
    • Damiano A.M., McGarth M.M., Willian M.K., Snyder C.F., LeWitt P.A., and Richter R.R. Evaluation of a measurement strategy for Parkinson's disease: patient health-related quality of life. Qual. Life Res. 9 (2000) 87-100
    • (2000) Qual. Life Res. , vol.9 , pp. 87-100
    • Damiano, A.M.1    McGarth, M.M.2    Willian, M.K.3    Snyder, C.F.4    LeWitt, P.A.5    Richter, R.R.6
  • 14
    • 0025298139 scopus 로고
    • Primate models of movements disorders of basal ganglia origin
    • DeLong M.R. Primate models of movements disorders of basal ganglia origin. Trends Neurosci. 13 (1990) 281-285
    • (1990) Trends Neurosci. , vol.13 , pp. 281-285
    • DeLong, M.R.1
  • 15
    • 0033452890 scopus 로고    scopus 로고
    • Worsening of levodopa-induced dyskinesias by motor and mental tasks
    • Durif F., Vidailhet M., Debilly B., and Agid Y. Worsening of levodopa-induced dyskinesias by motor and mental tasks. Mov. Disord. 14 (1999) 242-245
    • (1999) Mov. Disord. , vol.14 , pp. 242-245
    • Durif, F.1    Vidailhet, M.2    Debilly, B.3    Agid, Y.4
  • 16
    • 0034896299 scopus 로고    scopus 로고
    • The relationship between physiological tremor and the performance of rapid alternating movements in healthy elderly subjects
    • Duval C., Panisset M., and Sadikot A.F. The relationship between physiological tremor and the performance of rapid alternating movements in healthy elderly subjects. Exp. Brain Res. 139 (2001) 412-418
    • (2001) Exp. Brain Res. , vol.139 , pp. 412-418
    • Duval, C.1    Panisset, M.2    Sadikot, A.F.3
  • 17
    • 33646113256 scopus 로고    scopus 로고
    • C. Duval, M. Panisset, A.P. Strafella, A.F. Sadikot, The impact of ventrolateral thalamotomy on tremor and bradykinesia in patients with Parkinson's disease, Exp. Brain Res. (November) (2005) 1-12 [Epub ahead of print].
  • 18
    • 0034109726 scopus 로고    scopus 로고
    • The spectrum of levodopa-induced LID
    • Fahn S. The spectrum of levodopa-induced LID. Ann. Neurol. 47 Suppl. 1 (2000) S2-S11
    • (2000) Ann. Neurol. , vol.47 , Issue.SUPPL. 1
    • Fahn, S.1
  • 19
    • 0030966019 scopus 로고    scopus 로고
    • Identification and characterization of neurons with tremor-frequency activity in human globus pallidus
    • Hutchison W.D., Lozano A.M., Tasker B.R., Lang A.E., and Dostrovsky J.O. Identification and characterization of neurons with tremor-frequency activity in human globus pallidus. Exp. Brain Res. 113 (1997) 557-563
    • (1997) Exp. Brain Res. , vol.113 , pp. 557-563
    • Hutchison, W.D.1    Lozano, A.M.2    Tasker, B.R.3    Lang, A.E.4    Dostrovsky, J.O.5
  • 20
    • 20444489689 scopus 로고    scopus 로고
    • Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations
    • Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov. Disord. 20 Suppl. 11 (2005) S11-S16
    • (2005) Mov. Disord. , vol.20 , Issue.SUPPL. 11
    • Jankovic, J.1
  • 21
    • 0029116210 scopus 로고
    • Adverse reactions to controlled release levodopa/carbidopa in older persons: case control
    • Joseph C.L., Siple J., McWhorter J.K., and Camicioli R. Adverse reactions to controlled release levodopa/carbidopa in older persons: case control. J. Am. Geriatr. Soc. 43 (1995) 939-940
    • (1995) J. Am. Geriatr. Soc. , vol.43 , pp. 939-940
    • Joseph, C.L.1    Siple, J.2    McWhorter, J.K.3    Camicioli, R.4
  • 24
    • 2342442070 scopus 로고    scopus 로고
    • Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations
    • Parkinson Study Group
    • Marras C., Lang A., Krahn M., Tomlinson G., Naglie G., and Parkinson Study Group. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations. Mov. Disord. 19 (2004) 22-28
    • (2004) Mov. Disord. , vol.19 , pp. 22-28
    • Marras, C.1    Lang, A.2    Krahn, M.3    Tomlinson, G.4    Naglie, G.5
  • 25
    • 0002789021 scopus 로고
    • "On-Off" phenomenon in Parkinson's disease
    • Rinne U.K., Klinger M., and Stamm G. (Eds), Elsevier/North-Holland Biomedical Press, Amsterdam/New York
    • Marsden C.D. "On-Off" phenomenon in Parkinson's disease. In: Rinne U.K., Klinger M., and Stamm G. (Eds). Parkinson's disease: Current progress, Problems and Management (1980), Elsevier/North-Holland Biomedical Press, Amsterdam/New York 241-254
    • (1980) Parkinson's disease: Current progress, Problems and Management , pp. 241-254
    • Marsden, C.D.1
  • 26
    • 0018352370 scopus 로고
    • Early-morning dystonias: a late side effect of long-term levodopa therapy in Parkinson's disease
    • Melamed E. Early-morning dystonias: a late side effect of long-term levodopa therapy in Parkinson's disease. Arch. Neurol. 36 (1979) 308-310
    • (1979) Arch. Neurol. , vol.36 , pp. 308-310
    • Melamed, E.1
  • 28
    • 0017468670 scopus 로고
    • Patterns of dystonia ("I-D-I" and "D-I-D") in response to levodopa therapy of Parkinson's disease
    • Meunter M.D., Sharpless N.S., Tyce G.M., and Darley F.L. Patterns of dystonia ("I-D-I" and "D-I-D") in response to levodopa therapy of Parkinson's disease. Mayo Clin. Proc. 52 (1977) 163-174
    • (1977) Mayo Clin. Proc. , vol.52 , pp. 163-174
    • Meunter, M.D.1    Sharpless, N.S.2    Tyce, G.M.3    Darley, F.L.4
  • 29
    • 0025355032 scopus 로고
    • Levodopa-induced dyskinesias: review, observations and speculations
    • Nutt J.G. Levodopa-induced dyskinesias: review, observations and speculations. Neurology 40 (1990) 340-345
    • (1990) Neurology , vol.40 , pp. 340-345
    • Nutt, J.G.1
  • 30
    • 0035225372 scopus 로고    scopus 로고
    • Fluctuations in response to treatment for Parkinson's disease
    • Nutt J.G. Fluctuations in response to treatment for Parkinson's disease. Adv. Neurol. 86 (2001) 361-366
    • (2001) Adv. Neurol. , vol.86 , pp. 361-366
    • Nutt, J.G.1
  • 31
    • 0034905501 scopus 로고    scopus 로고
    • Motor fluctuations and dyskinesia in Parkinson's disease
    • Nutt J.G. Motor fluctuations and dyskinesia in Parkinson's disease. Parkinsonism Relat. Disord. 8 (2001) 101-108
    • (2001) Parkinsonism Relat. Disord. , vol.8 , pp. 101-108
    • Nutt, J.G.1
  • 32
    • 0034109592 scopus 로고    scopus 로고
    • Pathophysiology of levodopa-induced dyskinesias in parkinson's disease: Problem with the current model
    • Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., DeLong M.R., and Olanow C.W. Pathophysiology of levodopa-induced dyskinesias in parkinson's disease: Problem with the current model. Ann. Neurol. 47 Suppl. 1 (2000) S22-S34
    • (2000) Ann. Neurol. , vol.47 , Issue.SUPPL. 1
    • Obeso, J.A.1    Rodriguez-Oroz, M.C.2    Rodriguez, M.3    DeLong, M.R.4    Olanow, C.W.5
  • 33
    • 0020966363 scopus 로고
    • A method for quantification of alternate pronation and supination of forearms
    • Okada M., and Okada M. A method for quantification of alternate pronation and supination of forearms. Comput. Biomed. Res. 16 (1983) 59-78
    • (1983) Comput. Biomed. Res. , vol.16 , pp. 59-78
    • Okada, M.1    Okada, M.2
  • 34
    • 0031882302 scopus 로고    scopus 로고
    • Cortical motor overactivation in parkinsonian patients with l-dopa-induced peak-dose dyskinesia
    • Rascol O., Sabatini U., Brefel C., et al. Cortical motor overactivation in parkinsonian patients with l-dopa-induced peak-dose dyskinesia. Brain 121 (1998) 527-533
    • (1998) Brain , vol.121 , pp. 527-533
    • Rascol, O.1    Sabatini, U.2    Brefel, C.3
  • 36
    • 0034086805 scopus 로고    scopus 로고
    • The EQ-5D-a generic quality of life measure is a useful instrument to measure quality of life in patients with Parkinson's disease
    • Schrag A., Selai C., Jahanshahi M., and Quin N.P. The EQ-5D-a generic quality of life measure is a useful instrument to measure quality of life in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 69 (2000) 67-73
    • (2000) J. Neurol. Neurosurg. Psychiatry , vol.69 , pp. 67-73
    • Schrag, A.1    Selai, C.2    Jahanshahi, M.3    Quin, N.P.4
  • 37
    • 0037046987 scopus 로고    scopus 로고
    • Preference-based quality of life in patients with Parkinson's disease
    • Siderowf A., Ravina B., and Glick H.A. Preference-based quality of life in patients with Parkinson's disease. Neurology 59 (2002) 103-108
    • (2002) Neurology , vol.59 , pp. 103-108
    • Siderowf, A.1    Ravina, B.2    Glick, H.A.3
  • 38
    • 0033820838 scopus 로고    scopus 로고
    • Coordination disorders in patients with Parkinson's disease: A study of paced rhythmic forearm movements
    • Van den Berg C., Beck P.J., Wagenaar R.C., and van Wieringen P.C.W. Coordination disorders in patients with Parkinson's disease: A study of paced rhythmic forearm movements. Exp. Brian Res. 134 (2000) 174-186
    • (2000) Exp. Brian Res. , vol.134 , pp. 174-186
    • Van den Berg, C.1    Beck, P.J.2    Wagenaar, R.C.3    van Wieringen, P.C.W.4
  • 39
    • 0034105157 scopus 로고    scopus 로고
    • Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia
    • Vitek J.L., and Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia. Ann. Neurol. 47 Suppl. 1 (2000) S131-S140
    • (2000) Ann. Neurol. , vol.47 , Issue.SUPPL. 1
    • Vitek, J.L.1    Giroux, M.2
  • 40
    • 0030463523 scopus 로고    scopus 로고
    • Functional and pathophysiological models of the basal ganglia
    • Wichmann T., and DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6 (1996) 751-758
    • (1996) Curr. Opin. Neurobiol. , vol.6 , pp. 751-758
    • Wichmann, T.1    DeLong, M.R.2
  • 41
    • 24344503764 scopus 로고    scopus 로고
    • Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
    • Wenzelburger R. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?. Clin. Neurophysiol. 116 (2005) 1977-1978
    • (2005) Clin. Neurophysiol. , vol.116 , pp. 1977-1978
    • Wenzelburger, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.